Participant Flow Module
The Participant Flow Module provides information about the flow of participants through each stage of the clinical trial. This includes pre-assignment details, recruitment information, and the types of units analyzed, helping researchers understand how participants move through the study.
Participant Flow Module path is as follows:
Study -> Results Section -> Participant Flow Module
Participant Flow Module
Ignite Creation Date:
2025-12-24 @ 4:15 PM
Ignite Modification Date:
2025-12-25 @ 2:13 PM
NCT ID:
NCT04501666
Pre Assignment Details:
A total of 286 participants were randomized to receive either nemolizumab (CD14152) or placebo.
Recruitment Details:
The study was conducted at 77 sites in 10 countries.
Study:
NCT04501666
Study Brief:
Results Section:
NCT04501666